PND46 Relationship Between Patient Adherence to Treatment and Spanish Hospital Pharmacy'S Unmet Needs for the Management of Multiple Sclerosis

DIS patients. DIS patients had higher ER AD-related costs compared to CON patients ($135[680] v $53[343] p 0.011). CONCLUSIONS: Significantly less AD-related health care utilization and costs were associated with continued D23 use compared to patients who discontinued. More patients who continued therapy had 60 days on donepezil 10mg before starting the D23 treatment vs DIS patients, suggesting patients receive 60 days of 10 mg prior to initiating D23.